NEJM article points to avian flu resistance to Tamiflu

Share this article:
Two patients with avian flu, who were treated with Roche's Tamiflu, developed resistance to the drug and died, according to an article in the New England Journal of Medicine (NEJM).
The NEJM article examined the outcome of eight Vietnamese patients diagnosed with H5N1 influenza strain, known as avian or bird flu, and treated with Roche's Tamiflu.
The article showed that four patients lived and four died, suggesting that Tamiflu still has the potential to successfully treat patients infected with avian flu.
However, the NEJM article also suggests that H5N1 can become resistant to Tamiflu when used at current doses.
One of the patients, a 13-year-old girl, died despite receiving Tamiflu within 48 hours of the onset of symptoms, when the drug is believed to be most effective.
David Reddy, Roche's influenza-pandemic task-force leader said in a Wall Street Journal report today that the NEJM article is "a very good basis for learning and determining what we can glean from this and what additional work needs to be done."
Reddy also said that Roche is hoping soon to begin, in collaboration with the World Health Organization and the National Institutes of Health, a study in humans who become infected with avian flu to see if a doubling of the current dose is more effective.
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

FDA lifts OncoMed partial hold

The FDA froze the clinical trial of anti-Fzd7 vantictumab in July over concern about "bone-related adverse events."

Research links estrogen and binge eating

Baylor College of Medicine researchers have found that an estrogen replacement suppressed binge-eating behavior among lab mice.

Apple selfies spur diabetes donations

Jazz apples has launched a Crunch to Contribute campaign to raise money for one of two diabetes associations.